By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mologen AG 

P.O. Box 332140

Berlin    D - 14180  Germany
Phone: 49-0-30-857-576-0 Fax: 49-0-30-857-576-50


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





Company News
Mologen AG (MOLGF.PK): Presentation On IMPACT Study At ESMO Symposium On Immuno-Oncology 11/17/2014 1:27:53 PM
Mologen AG (MOLGF.PK) Publishes Nine Month Report For 2014: Launch Of Pivotal Study For The Cancer Immunotherapy MGN1703 11/13/2014 9:51:51 AM
Mologen AG (MOLGF.PK): Presentation Of DNA Vaccine Against Leishmaniasis At IMED 2014 11/3/2014 12:54:28 PM
Mologen AG (MOLGF.PK): Successful Investigator Meetings For IMPALA Colorectal Cancer Trial 10/20/2014 11:08:34 AM
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014 10:53:05 AM
Mologen AG (MOLGF.PK): Three Poster Presentations At ESMO 2014 Congress 9/18/2014 1:06:27 PM
Mologen AG (MOLGF.PK): Initiation Of Phase 3 IMPALA Study With Immunotherapy MGN1703 In Colorectal 9/11/2014 9:52:11 AM
Mologen AG (MOLGF.PK): General Meeting Votes In Favour Of All Proposed Resolutions And Elects New Supervisory Board Members 8/15/2014 12:04:21 PM
Mologen AG (MOLGF.PK): Preparation And Launch Of New Studies Characterized The First Half-Year 2014 8/13/2014 1:01:20 PM
Mologen AG (MOLGF.PK): First Approvals For Phase III IMPALA Colorectal Cancer Study 8/4/2014 8:32:15 AM
123456789
//-->